Zobrazeno 1 - 10
of 18
pro vyhledávání: '"O. A. ZEMLYANSKAYA"'
Publikováno v:
Атеротромбоз, Vol 11, Iss 2, Pp 122-134 (2022)
A fatal case of severe stenosis of the aortic orifice in a patient with not diagnosed in time, long-term persistent covid infection is presented. The patient was hospitalized to resolve the issue of surgical correction of the aortic stenosis. On admi
Externí odkaz:
https://doaj.org/article/e303bdd64d6d42a7b7fa1b4d4a065ee3
Publikováno v:
Терапевтический архив, Vol 92, Iss 9, Pp 15-23 (2020)
Aim.To analyze the frequency of resumption of anticoagulant therapy (ACT) after major and clinically significant bleeding among AF patients who received oral anticoagulants and were observed in the Department of clinical problems of atherothrombosis
Externí odkaz:
https://doaj.org/article/7b614968abfd462aa40524e58bb1f955
Autor:
O. A. Zemlyanskaya, E. S. Kropacheva
Publikováno v:
Атеротромбоз, Vol 0, Iss 1, Pp 62-71 (2019)
The use of modern oral anticoagulants is associated with a significant reduction in the risk of stroke and systemic embolism in patients with atrial fibrillation, and thus with an increase in the life expectancy of patients. That is why multicomponen
Externí odkaz:
https://doaj.org/article/fbd3f778e33c46dc8b8270da1877ab38
Publikováno v:
Атеротромбоз, Vol 0, Iss 1, Pp 107-121 (2018)
Assessment of kidney function is mandatory in all cardiac patients, and patients with atrial fibrillation represent a category of patients with high thrombotic risk, which increases the risk of decreased kidney function during follow-up. Controversia
Externí odkaz:
https://doaj.org/article/49902e4a8bea41b4869478bf7aa7d38b
Publikováno v:
Атеротромбоз, Vol 0, Iss 2, Pp 115-130 (2017)
Atrial fibrillation (AF) is the most common indication for the long-term oral anticoagulation therapy. For several decades, vitamin K antagonists have been the mainstay of routine clinical practice.A prospective 10-year follow-up of patients with atr
Externí odkaz:
https://doaj.org/article/d02d6c7ca8de45cfa0f46451459d5150
Publikováno v:
Терапевтический архив, Vol 89, Iss 9, Pp 78-86 (2017)
Aim. To investigate the prognostic value of renal function and to estimate glomerular filtration rate (GFR) changes during a 5-year follow-up of patients receiving warfarin therapy. Subjects and methods. 200 patients (124 men, 76 women) mainly from a
Externí odkaz:
https://doaj.org/article/0cb035c1634842458b75c21605f5920e
Publikováno v:
Атеротромбоз, Vol 0, Iss 1, Pp 145-162 (2017)
Despite the long-term clinical experience, bleeding remains the greatest danger for patients taking vitamin K antagonists. Moreover, even the presence of risk factors for hemorrhagic complications in a patient should not be the only reason for cancel
Externí odkaz:
https://doaj.org/article/26ea96fc370c4159bb001b41b2ee9140
Publikováno v:
Терапевтический архив, Vol 92, Iss 9, Pp 15-23 (2020)
To analyze the frequency of resumption of anticoagulant therapy (ACT) after major and clinically significant bleeding among AF patients who received oral anticoagulants and were observed in the Department of clinical problems of atherothrombosis from
Autor:
Titaeva Ev, E. S. Kropacheva, A. B. Dobrovolsky, Elizaveta Panchenko, N. M. Vorobyeva, O.V. Moreva, O. A. Zemlyanskaya
Publikováno v:
European Heart Journal. 39
[Renal function in patients receiving long-term warfarin therapy: A five-year prospective follow-up]
Publikováno v:
Терапевтический архив, Vol 89, Iss 9, Pp 78-86 (2017)
To investigate the prognostic value of renal function and to estimate glomerular filtration rate (GFR) changes during a 5-year follow-up of patients receiving warfarin therapy.200 patients (124 men, 76 women) mainly from a group at high risk for thro